ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Friesland Bank Aandelen Fds NV

Friesland Bank Aandelen Fds NV (OPWAF)

63.53
0.71
(1.13%)
Closed 05 January 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
63.53
Bid
0.00
Offer
0.00
Volume
1,608
63.53 Day's Range 63.53
53.81 52 Week Range 65.37
Previous Close
62.82
Open
63.53
Last Trade
1
@
63.53
Last Trade Time
Average Volume (3m)
15,911
Financial Volume
-
VWAP
-

OPWAF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-0.18853102906563.6563.6562.7960363.07978864DE
4-1.31-2.0203578038264.8465.3762.79148563.77245643DE
121.522.4512175455662.0165.3760.991591163.44188079DE
264.337.3141891891959.265.3756.54840062.76304016DE
528.515.44612029855.0365.3753.81523061.82002056DE
15613.2226.27708209150.3165.3744.37384255.61359398DE
26022.5354.95121951224165.3727.91444748.02534058DE

OPWAF - Frequently Asked Questions (FAQ)

What is the current Friesland Bank Aandelen ... share price?
The current share price of Friesland Bank Aandelen ... is 63.53 €
What is the 1 year trading range for Friesland Bank Aandelen ... share price?
Friesland Bank Aandelen ... has traded in the range of 53.81 € to 65.37 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M

Discussion

View Full Feed
devil dog 96 devil dog 96 12 seconds ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 13 seconds ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 4 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 4 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 24 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 27 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 28 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 28 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 29 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 31 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 32 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 33 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 34 minutes ago
Probably
AVXL
HokieHead HokieHead 36 minutes ago
Wrong..
TWOH
HokieHead HokieHead 36 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 38 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 39 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 40 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 40 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 41 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 42 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 42 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 45 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL

Your Recent History

Delayed Upgrade Clock